Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study. [electronic resource]
- Breast cancer research : BCR Jun 2011
- R55 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1465-542X
10.1186/bcr2891 doi
Adult Aged Aged, 80 and over Biomarkers, Tumor--blood Breast Neoplasms--diagnosis C-Reactive Protein--metabolism Cohort Studies Disease-Free Survival Female Follow-Up Studies Humans Middle Aged Neoplasm Recurrence, Local Prognosis Risk Factors